![glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication Anti-GLP-1 antibody [EPR4042-1] (ab108443) |](https://ars.els-cdn.com/content/image/1-s2.0-S0006295218300297-fx1.jpg)
![glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication Anti-GLP-1 antibody [EPR4042-1] (ab108443) |](https://images.novusbio.com/images/nbp1-97308_rabbit-polyclonal-glp-1r-antibody-310202415175291.jpg)
![glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication Anti-GLP-1 antibody [EPR4042-1] (ab108443) |](https://media.biocompare.com/m/37/images/ihc-immunohistchemistry-20381641-400x300.jpg)
![glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication Anti-GLP-1 antibody [EPR4042-1] (ab108443) |](https://static.wixstatic.com/media/1f382d_7e3cdf67a9c842d3b969a032e76991ff~mv2.jpg/v1/fill/w_568,h_192,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/1f382d_7e3cdf67a9c842d3b969a032e76991ff~mv2.jpg)
glp-1 antibody
Shipping Estimate
glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication Anti-GLP-1 antibody [EPR4042-1] (ab108443) |
USD26.77
USD76.77
Pay in 4 interest-free payments of $6.69 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
![glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication Anti-GLP-1 antibody [EPR4042-1] (ab108443) |](https://content.abcam.com/products/images/glp-1-antibody-epr4042-1-ab108443--immunocytochemistry-immunofluorescence-img108423.jpg)
![glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication Anti-GLP-1 antibody [EPR4042-1] (ab108443) |](https://www.bosterbio.com/media/catalog/product/antibody/pb9705-1-IHC-anti-glp1-picoband-antibody.jpg)
![glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication Anti-GLP-1 antibody [EPR4042-1] (ab108443) |](https://www.thermofisher.com/antibody/images/650/710320_WB.jpg?time=20240507)
![glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication Anti-GLP-1 antibody [EPR4042-1] (ab108443) |](https://ars.els-cdn.com/content/image/1-s2.0-S2666379121000793-fx1.jpg)
![glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication Anti-GLP-1 antibody [EPR4042-1] (ab108443) |](https://cdn.antibodies.com/image/catalog/83/A83537_3.jpg?profile=product_top)
